PE20060740A1 - Proceso de fabricacion de derivados de salicilamidas n-sustituidas - Google Patents

Proceso de fabricacion de derivados de salicilamidas n-sustituidas

Info

Publication number
PE20060740A1
PE20060740A1 PE2005001448A PE2005001448A PE20060740A1 PE 20060740 A1 PE20060740 A1 PE 20060740A1 PE 2005001448 A PE2005001448 A PE 2005001448A PE 2005001448 A PE2005001448 A PE 2005001448A PE 20060740 A1 PE20060740 A1 PE 20060740A1
Authority
PE
Peru
Prior art keywords
substituted
salicilamides
derivatives
manufacturing process
saliciloyl
Prior art date
Application number
PE2005001448A
Other languages
English (en)
Spanish (es)
Inventor
Bernhard Riss
Ulrich Meier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34090175&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20060740(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20060740A1 publication Critical patent/PE20060740A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PE2005001448A 2004-12-16 2005-12-14 Proceso de fabricacion de derivados de salicilamidas n-sustituidas PE20060740A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0427603.6A GB0427603D0 (en) 2004-12-16 2004-12-16 Organic compounds

Publications (1)

Publication Number Publication Date
PE20060740A1 true PE20060740A1 (es) 2006-09-04

Family

ID=34090175

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005001448A PE20060740A1 (es) 2004-12-16 2005-12-14 Proceso de fabricacion de derivados de salicilamidas n-sustituidas

Country Status (24)

Country Link
US (1) US8461385B2 (cg-RX-API-DMAC7.html)
EP (2) EP2955171A1 (cg-RX-API-DMAC7.html)
JP (1) JP5224816B2 (cg-RX-API-DMAC7.html)
KR (1) KR101287233B1 (cg-RX-API-DMAC7.html)
CN (1) CN101080384B (cg-RX-API-DMAC7.html)
AR (1) AR055007A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005315850B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0519327A2 (cg-RX-API-DMAC7.html)
CA (1) CA2587213C (cg-RX-API-DMAC7.html)
ES (1) ES2547349T3 (cg-RX-API-DMAC7.html)
GB (1) GB0427603D0 (cg-RX-API-DMAC7.html)
GT (1) GT200500353A (cg-RX-API-DMAC7.html)
IL (1) IL183366A0 (cg-RX-API-DMAC7.html)
MA (1) MA29092B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007007211A (cg-RX-API-DMAC7.html)
NO (1) NO338969B1 (cg-RX-API-DMAC7.html)
PE (1) PE20060740A1 (cg-RX-API-DMAC7.html)
PL (1) PL1838664T3 (cg-RX-API-DMAC7.html)
PT (1) PT1838664E (cg-RX-API-DMAC7.html)
RU (1) RU2404158C2 (cg-RX-API-DMAC7.html)
TN (1) TNSN07229A1 (cg-RX-API-DMAC7.html)
TW (1) TW200635880A (cg-RX-API-DMAC7.html)
WO (1) WO2006063821A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200703826B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006292337B8 (en) 2005-09-19 2013-02-07 Emisphere Technologies, Inc. Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
MX2010004716A (es) 2007-11-02 2010-12-17 Emisphere Tech Inc Metodo para tratar la deficiencia de vitamina b12.
CN109473182B (zh) * 2018-11-12 2021-10-19 北京北排科技有限公司 一种基于深度信念网络的mbr膜透水率智能检测方法
BR112021023195A2 (pt) * 2019-05-20 2022-02-15 Lonza Guangzhou Pharmaceutical Ltd Método para preparação de carsalam
CN115260116B (zh) * 2022-08-19 2024-04-12 株洲壹诺生物技术有限公司 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU382610A1 (ru) * 1968-07-08 1973-05-25 Способ получения амидов карбоновых кислот
ES2235854T3 (es) * 1999-04-05 2005-07-16 Emisphere Technologies, Inc. Sales disodicas, monohidratos y solvatos etanolicos para aportar agentes activos.
OA11972A (en) * 1999-06-25 2006-04-18 Inst For Pharmaceutical Substituted phenoxyacetic acids.
US6900344B2 (en) * 2000-03-21 2005-05-31 Emisphere Technologies, Inc. Method of preparing alkylated salicylamides via a dicarboxylate intermediate
WO2001092206A1 (en) 2000-06-02 2001-12-06 Emisphere Technologies, Inc. Method of preparing salicylamides
CA2411754C (en) * 2000-06-29 2009-05-26 Emisphere Technologies, Inc. 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
AU2001296865A1 (en) * 2000-09-06 2002-03-22 Emisphere Technologies, Inc. (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
AU2003223158B2 (en) * 2002-01-09 2008-01-17 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
JP4417113B2 (ja) 2002-02-20 2010-02-17 エミスフェアー・テクノロジーズ・インク Glp−1分子の投与方法
US20050054557A1 (en) * 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin

Also Published As

Publication number Publication date
ZA200703826B (en) 2008-08-27
TW200635880A (en) 2006-10-16
AR055007A1 (es) 2007-08-01
ES2547349T3 (es) 2015-10-05
AU2005315850B2 (en) 2009-11-05
JP2008524142A (ja) 2008-07-10
IL183366A0 (en) 2007-09-20
RU2007126972A (ru) 2009-01-27
PL1838664T3 (pl) 2016-04-29
GB0427603D0 (en) 2005-01-19
MA29092B1 (fr) 2007-12-03
US20090253811A1 (en) 2009-10-08
CN101080384B (zh) 2011-06-15
US8461385B2 (en) 2013-06-11
EP1838664B1 (en) 2015-07-15
TNSN07229A1 (en) 2008-11-21
WO2006063821A1 (en) 2006-06-22
RU2404158C2 (ru) 2010-11-20
KR101287233B1 (ko) 2013-07-17
BRPI0519327A2 (pt) 2009-01-13
KR20070086276A (ko) 2007-08-27
EP1838664A1 (en) 2007-10-03
MX2007007211A (es) 2007-08-15
NO338969B1 (no) 2016-11-07
PT1838664E (pt) 2015-10-16
NO20073548L (no) 2007-09-17
CA2587213A1 (en) 2006-06-22
AU2005315850A1 (en) 2006-06-22
GT200500353A (es) 2006-07-17
JP5224816B2 (ja) 2013-07-03
CA2587213C (en) 2015-05-19
EP2955171A1 (en) 2015-12-16
CN101080384A (zh) 2007-11-28

Similar Documents

Publication Publication Date Title
CR9221A (es) Procesos para preparar eteres aromaticos
ES2191977T3 (es) Soluciones y dispersiones en estado solido de farmacos poco solubles en agua.
NO20031970D0 (no) Optiske lysgjöringsmiddelblandinger, deres fremstilling og deres anvendelser
TR200103095T2 (tr) Renin engelleyiciler.
GB0229695D0 (en) Solid-phase preparation of 18F-labelled amino acids
MXPA04004301A (es) Bencimidazoles sustituidos utiles como inhibidores de la proteina cinasa.
PE20060740A1 (es) Proceso de fabricacion de derivados de salicilamidas n-sustituidas
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
NO20034667L (no) Arylsulfonamider som antivirale midler
DE60221508D1 (de) Aminosäurederivate als hiv-protease-inhibitoren
GT200100251A (es) Procedimiento para la preparacion de imidazotriazinonas substituidas con sulfonamida
MXPA03010766A (es) Nuevos compuestos y composiciones como inhibicores de las catepsinas.
ATE489077T1 (de) Schnell lösliche formulierung von nichtsteroidalen antiphlogistika
TNSN07228A1 (en) Manufacture process of organic compounds
UY27413A1 (es) Agonistas de la oxitocina
SG135139A1 (en) Polishing agent
EA200601589A1 (ru) Производные 7h-8,9-дигидропирано-(2,3-c)имидазо(1,2a)пиридина и их применение в качестве ингибиторов секреции кислоты желудочного сока
MXPA04005210A (es) Procedimiento para la preparacion de composiciones que tienen una cantidad incrementada de sales farmaceuticamente activas de rotameros.
ATE315932T1 (de) Hemmer für das 20-hete-produzierende enzym
EA200400417A1 (ru) Новые безводные кристаллические формы габапентина
EA200700364A1 (ru) Производные амида кинуреновой кислоты как антагонисты nr2b подтипа рецептора nmda
WO2006006040A3 (en) News diamine salts of cephalosporin antibiotics and their preparation
EA200101113A1 (ru) Способ получения 2-(n-фениламино) бензойных кислот
PE20091776A1 (es) 4-butiratos de trimetilamonio como inhibidores de la cpt2
AR032585A1 (es) Procedimiento para preparar composiciones farmaceuticas en comprimidos de desintegracion rapida sustancialmente exentos de cristales del principio farmacologicamente activo provenientes de la modificacion de la estructura cristalina de dicho agente durante las operaciones de fabricacion de los mismo

Legal Events

Date Code Title Description
FD Application declared void or lapsed